Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis
NCT04979832Phase 2Unknown
- Sponsor
- Zealand University Hospital
- Start
- Sep 2021
- Primary completion
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of granulocyte macrophage-colony stimulating factor in pouchitis, sponsored by Zealand University Hospital. Status: unknown.
02
Drugs
granulocyte macrophage-colony stimulating factor
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT04979832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04979832.